Financhill
Back

Bioventus Stock Predictions

Bioventus Stock Forecast

  • Is Bioventus Stock Undervalued?
    The current Bioventus [BVS] share price is $3.97. The Score for BVS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Bioventus Stock Go Up Next Year?

Data Unavailable

Bioventus Stock Rating

Data Unavailable

Bioventus Stock Price History

Is BVS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BVS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
bioventus.com

52-Week Data

52-Week High:
6.08
52-Week Low:
0.90

Prediction Charts

Market Cap:
253.4M
Price in USD:
3.97
Volume:
53K
Beta:
0.65

Technical Analysis

SMA50:
4.87
SMA100:
4.84
SMA200:
4.21
52-Wk Change:
324.46%

Stock Predictions

  • Is Bioventus stock public?
    Yes, Bioventus is a publicly traded company.
  • What is the Bioventus stock quote today?
    The Bioventus stock price is 3.97 USD today.
  • How to buy Bioventus stock online?
    You can buy Bioventus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 4.65 4.64 4.66 4.53
Apr-17 4.67 4.70 4.86 4.57
Apr-18 4.71 4.57 4.76 4.50
Apr-19 4.55 4.48 4.62 4.44
Apr-22 4.60 4.29 4.60 4.25
Apr-23 4.31 4.31 4.45 4.29
Apr-24 4.23 4.15 4.32 4.10
Apr-25 4.12 4.07 4.15 4.06
Apr-26 4.08 3.98 4.09 3.95
Apr-29 4.00 4.07 4.29 3.98
Apr-30 4.03 3.96 4.17 3.90
May-1 3.96 3.99 4.07 3.93
May-2 4.03 3.95 4.03 3.95
May-3 4.04 3.97 4.12 3.94

Bioventus Earnings

Data Unavailable

Bioventus Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.46 per share, and an increase next year of $0.21 per share.

* Bioventus stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.